Vagisil Anti-itch Medicated Creme Maximum Strength Cream
Product Images NDC 11509-4402

1 FDA label image from Combe Incorporated · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Vagisil Anti-itch Medicated Creme Maximum Strength (NDC 11509-4402). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Combe Incorporated, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelvagisil®maximum Strengthanti-itch Cremenet Wt. 1 Oz. (28 G) (Vagisil Maximum Strength Anti Itch Creme 01)

Principal Display Panelvagisil®maximum Strengthanti-itch Cremenet Wt. 1 Oz. (28 G) (Vagisil Maximum Strength Anti Itch Creme 01)
Packaging label for Vagisil Maximum Strength Anti-Itch Creme, a topical cream containing benzocaine 20% and resorcinol 3% as active ingredients. The label highlights its use for temporary relief of external vaginal itching, product features, and directions for use. It is manufactured by Combe Incorporated and includes dosage instructions, warnings, inactive ingredients, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.